Fluorosayoka 500mg/ml Injection
Marketer
Sayoka Pharmaceutical (OPC) Pvt Ltd
Salt Composition
Fluorouracil (500mg/ml)
Overview Fluorosayoka 500mg/ml Injection
Sayoka-F 500mg/ml injection treats various cancers, including those affecting the stomach, colon, rectum, breast, and lungs. Its use may extend to other conditions, as directed by a physician. It's frequently administered in conjunction with other medications as part of a combined chemotherapy regimen. Administration is strictly via intravenous injection under medical supervision. Dosage and frequency are determined individually by your doctor, based on your specific condition and may vary over time. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under your physician's guidance. Common side effects encompass heightened infection risk, mouth sores, nausea, vomiting, and fatigue. The medication can lower blood cell counts (red and white), increasing infection vulnerability. Regular blood tests monitoring blood cell levels, along with liver, heart, and uric acid levels, are essential. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all medications you are currently taking, including antibiotics. Interactions with other drugs are possible. Use during pregnancy or breastfeeding is contraindicated. Employing effective contraception by both partners throughout the treatment period is crucial to prevent pregnancy.
Uses of Fluorosayoka 500mg/ml Injection
Malignant neoplasm
Major Benefits of Fluorosayoka 500mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fluorosayoka 500mg/ml Injection:
- Nausea
- Vomiting
- Hair loss
- Diarrhea
- Bronchospasm
- Infection
- Myelosuppression
- Agranulocytosis (deficiency of granulocytes in the blood)
- General discomfort
- Itching
- Skin exfoliation
- Anemia (low number of red blood cells)
- Febrile neutropenia
- Angina (heart related chest pain)
- ECG changes
- Decreased immunity
How to use Fluorosayoka 500mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fluorosayoka 500mg/ml Injection works:
Sayoka 500mg/ml Injection, an oncology agent, inhibits the replication of cancerous cells' genetic material (DNA and RNA), thereby arresting their proliferation and ultimately causing their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fluorosayoka 500mg/ml Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Fluorosayoka 500mg/ml Injection during pregnancy is contraindicated due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential advantages outweigh the hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Fluorosayoka 500mg/ml Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Fluorosayoka 500mg/ml Injection may induce side effects potentially impairing driving ability. These side effects can include nausea and neurological adverse events, including visual disturbances, thus impacting safe driving.
KidneySAFE IF PRESCRIBED
The injectable medication Fluorosayoka (500mg/ml) is likely safe for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Fluorosayoka 500mg/ml Injection cautiously, as dosage modifications may be necessary. Physician consultation is advised.
What if you forget to take Fluorosayoka 500mg/ml Injection :
NA
Facts to Know About Fluorosayoka 500mg/ml Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Base Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Action class | Metabolic inhibitors |
3,018 People bought this recently